2022

Thomas Polen CEO BD Not only did the Secaucus-based company successfully execute the spinoff of its diabetes care business on April 1, which is now a standalone and publicly traded company named Embecta, it also reported revenue...

Stuart Peltz Founder & CEO PTC Therapeutics With a background in academia, and a recognized scientific leader in RNA biology, PTC has grown from a research organization to a publicly traded, global commercial organization with multiple approved...

Kristin Peck CEO Zoetis Since she took over as CEO in January 2020, Zoetis has created $30 billion in market cap value and its stock (now approximately $200 a share) is up 50%. Makes you wonder why...

Dean Paranicas CEO & president HealthCare Institute of N.J. Prefers facts over fiction when it comes to health care, including stats like this: In 2018-20, only 49.5% of money spent on brand drugs went to bio companies....

John Oyler BeiGene With the groundbreaking of BeiGene's new U.S. manufacturing and clinical research & development center in Hopewell, Oyler is seeing his vision become a reality. He has an incredible commitment and passion to fighting...

Eric Orlando Executive vice president Kaufman Zita Group While he has been providing legislative and public affairs counsel to a variety of clients for more than a decade, he is also the first executive director of the...

Simon Nynens CEO N.J. Innovation Institute Heads NJII, a New Jersey Institute of Technology corporation that helps turn ideas into workable solutions across six divisions: biopharma, data and advanced technology, defense and homeland security, entrepreneurship, health care...

Wesley Mathews CEO & president Choose N.J. Taking over from Jose Lozano this past February, Mathews thinks Choose is ready for its next leap, wherever that may be. One thing for sure is, being able to impact...

Kevin Lyons Associate professor, supply chain management Rutgers Business School Under his guidance, Rutgers students have crafted and presented plans focused on supply chain management. His research has centered on how to integrate the different aspects of...

Daniel Loughlin Vice chairman, brokerage JLL He’s long been one of the top brokers in the state, and his specialty, life sciences, remains as consequential as ever. A self-proclaimed thoughtful risk-taker, Loughlin said his adventurous spirit has...